Purinergic regulation of hepatic inflammation and fibrosis and implications for liver surgery
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Berlin, Medizinische Fakultät Charité - Universitätsmedizin Berlin, Habilitationsschrift, 2022
- Keyword
-
Fibrosis
Inflammation
Liver--Surgery
- Event
-
Veröffentlichung
- (where)
-
Berlin
- (who)
-
Medizinische Fakultät Charité - Universitätsmedizin Berlin
- (when)
-
2022
- Creator
- DOI
-
10.17169/refubium-35091
- URN
-
urn:nbn:de:kobv:188-refubium-35375-2
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:53 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Feldbrügge, Linda
- Medizinische Fakultät Charité - Universitätsmedizin Berlin
Time of origin
- 2022
Other Objects (12)
Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis
Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis
Inflammation and fibrosis in the gastrointestinal tract and liver: Mechanisms and targets
Liver fibrosis and endocannabinoids
Editorial : Inflammation and Fibrosis in the Gastrointestinal Tract and LiverMechanisms and Targets
Circulating microRNAs as markers of liver inflammation, fibrosis and cancer
Analysis of the effects of xanthohumol on hepatic homeostasis, inflammation, fibrosis and cancerogenesis
Hepatic myeloid derived suppressor cells and their role in liver inflammation and hepatocarcinogenesis
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Chemokine receptor CCR6-dependent accumulation of IL-17 producing gamma/delta T cells in injured liver restricts hepatic inflammation and fibrosis
Fibrosis remodelling and ECM biomarkers in liver fibrosis
Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis
Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis
Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis
Inflammation and fibrosis in the gastrointestinal tract and liver: Mechanisms and targets
Liver fibrosis and endocannabinoids
Editorial : Inflammation and Fibrosis in the Gastrointestinal Tract and LiverMechanisms and Targets
Circulating microRNAs as markers of liver inflammation, fibrosis and cancer
Analysis of the effects of xanthohumol on hepatic homeostasis, inflammation, fibrosis and cancerogenesis
Hepatic myeloid derived suppressor cells and their role in liver inflammation and hepatocarcinogenesis
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Chemokine receptor CCR6-dependent accumulation of IL-17 producing gamma/delta T cells in injured liver restricts hepatic inflammation and fibrosis
Fibrosis remodelling and ECM biomarkers in liver fibrosis
Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis
Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis
Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis
Inflammation and fibrosis in the gastrointestinal tract and liver: Mechanisms and targets
Liver fibrosis and endocannabinoids
Editorial : Inflammation and Fibrosis in the Gastrointestinal Tract and LiverMechanisms and Targets
Circulating microRNAs as markers of liver inflammation, fibrosis and cancer
Analysis of the effects of xanthohumol on hepatic homeostasis, inflammation, fibrosis and cancerogenesis
Hepatic myeloid derived suppressor cells and their role in liver inflammation and hepatocarcinogenesis
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Chemokine receptor CCR6-dependent accumulation of IL-17 producing gamma/delta T cells in injured liver restricts hepatic inflammation and fibrosis
Fibrosis remodelling and ECM biomarkers in liver fibrosis